237 related articles for article (PubMed ID: 17402592)
1. [Effect of nebivolol on the blood oxygen transport].
Zinchuk VV; Zinchuk NV
Eksp Klin Farmakol; 2007; 70(1):44-7. PubMed ID: 17402592
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide effect on the hemoglobin-oxygen affinity.
Stepuro TL; Zinchuk VV
J Physiol Pharmacol; 2006 Mar; 57(1):29-38. PubMed ID: 16601313
[TBL] [Abstract][Full Text] [Related]
3. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.
Dessy C; Saliez J; Ghisdal P; Daneau G; Lobysheva II; Frérart F; Belge C; Jnaoui K; Noirhomme P; Feron O; Balligand JL
Circulation; 2005 Aug; 112(8):1198-205. PubMed ID: 16116070
[TBL] [Abstract][Full Text] [Related]
4. Collaborative therapy with nebivalol and L-NAME for spinal cord ischemia/reperfusion injury.
Seren M; Budak B; Turan N; Parlar AI; Akar F; Ulus AT
Ann Vasc Surg; 2008; 22(3):425-31. PubMed ID: 18466820
[TBL] [Abstract][Full Text] [Related]
5. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
8. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
Pronko TP; Zinchuk VV
Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
[TBL] [Abstract][Full Text] [Related]
9. Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
Prisant LM
J Clin Pharmacol; 2008 Feb; 48(2):225-39. PubMed ID: 18083889
[TBL] [Abstract][Full Text] [Related]
10. [Effect of simvastatin on the oxygen transport function and prooxidant - antioxidant balance in blood].
Glutkina NV
Eksp Klin Farmakol; 2013; 76(4):22-5. PubMed ID: 23762985
[TBL] [Abstract][Full Text] [Related]
11. Treatment with a highly selective β₁ antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats.
Hu T; Beattie WS; Mazer CD; Leong-Poi H; Fujii H; Wilson DF; Tsui AK; Liu E; Muhammad M; Baker AJ; Hare GM
Anesth Analg; 2013 Mar; 116(3):649-62. PubMed ID: 23400988
[TBL] [Abstract][Full Text] [Related]
12. [The involvement of nitric oxide in formation of hemoglobin oxygen-binding properties].
Zinchuk VV
Usp Fiziol Nauk; 2003; 34(2):33-45. PubMed ID: 12754789
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.
Reidenbach C; Schwinger RH; Steinritz D; Kehe K; Thiermann H; Klotz T; Sommer F; Bloch W; Brixius K
Life Sci; 2007 Jun; 80(26):2421-7. PubMed ID: 17512554
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers in the management of hypertension: focus on nebivolol.
Wojciechowski D; Papademetriou V
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
[TBL] [Abstract][Full Text] [Related]
15. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of nebivolol on oxygen free radical-induced vasoconstrictions in vitro.
Wagenfeld L; Himpel O; Galambos P; Matthiesen N; Wiermann A; Richard G; Klemm M; Zeitz O
Med Sci Monit; 2008 Jun; 14(6):BR109-112. PubMed ID: 18509268
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
19. NO metabolite flux across the human coronary circulation.
Rogers SC; Khalatbari A; Datta BN; Ellery S; Paul V; Frenneaux MP; James PE
Cardiovasc Res; 2007 Jul; 75(2):434-41. PubMed ID: 17512506
[TBL] [Abstract][Full Text] [Related]
20. Evolving mechanisms of action of beta blockers: focus on nebivolol.
Mason RP; Giles TD; Sowers JR
J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
